CERo Therapeutics Holdings, Inc. (CERO) stock
CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%
CERo Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CERo Therapeutics's enterprise value was -$789.50K on Apr 30, 2024.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2024 | Apr 30, 2024 | -$789.50K | – |
See a number that looks wrong?